Anti-hyperlipidaemic effects of an essential oil of Melissa officinalis. L in cholesterol-fed rabbits

Journal of Applied Biological Sciences

Volumn 4, Issue 1, 2010, Pages 17-22

  Karimi, Isaac ^a   Hayatgheybi, Hossein ^b   Razmjo, Mostafa ^a   Yousefi, Másume ^c   Dadyan, Amir ^d   Hadipour, Mohammadmehdi ^a  

^a RAZI UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c Veterinary Organization   (Iran)

^d UNIVERSITY OF ZABOL   (Iran)

Author keywords

Cholesterol; Essential oil; Hyperlipidaemia; Lemon balm; Triglycerides

Indexed keywords

CITRUS LIMON; MELISSA OFFICINALIS; ORYCTOLAGUS CUNICULUS;

EID: 79959780029     PISSN: 13071130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Hadaegh F, Zabetian A, Harati H, Azizi F. 2007. Metabolic syndrome in normal-weight Iranian adults. Ann Saudi Med 27:18-24.
2. Agajani Delavar M, Munn Sann L, Geok Lin K, Syed Tajuddin B. Hassan ST, Hanachi P. 2008. Total calcium intake and metabolic syndrome in middle aged women, Babol, Iran. World Appl Sci J 5: 193-198.
3. Agajani Delavar M, Lye MS, Khor GL, Hanachi P, Hassan ST. 2009. Prevalence of metabolic syndrome among middle aged women in Babol, Iran. outheast Asian J Trop Med Public Health 40:612-28.
4. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. 2009. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The National survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32: 1092-1097.
5. Cziraky MJ. 2004. Management of Dyslipidemia in Patients with Metabolic Syndrome. J Am Pharm Assoc 44: 478-488.
6. Kennedy D, Little OW, Haskell CF, Scholey AB. 2006. Anxiolytic effects of combination of Melissa officinalis and Valeriana officinalis during laboratory nduced stress. Phytother Res 20: 96-102.
7. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. 2003. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry 74:863-866.
8. de Sousa AC, Alviano DS, Blank AF, Alves PB, Alviano CS, Gattass CR. 2004. Melissa officinalis L. essential oil: antitumoral and antioxidant activities. Pharm Pharmacol 56: 677-681.
9. Mencherini T, Picerno P, Scesa C, Aquino R. 2007. Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis. J Nat Prod 70: 1889-894.
10. Schnitzler P, Schuhmacher A, Astani A, Reichling J. 2008. Melissa officinalis oil affects infectivity of enveloped herpesviruses. Phytomedicine 15:734.
11. Cetin H, Cinbilgel I, Yanikoglu A, Gokceoglu M. 2006. Larvicidal activity of some Labiatae (Lamiaceae) plant extracts from Turkey. Phytother Res 20:1088-1090.
12. Mimica-Dukic N, Bozin B, Sokovic M, Simin N. 2004. Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil. J Agric ood Chem 52: 2485-2489.
13. Aliabadi FH, Valadabadi SA, Daneshian J, Khalvati MA. 2009. Evaluation changing of essential oil of balm (Melissaofficinalis L.) under water deficit tress conditions. J Med Plant Res 3: 329-333.
14. Fecka I, Turek S. 2007. Determination of water-soluble polyphenolic compounds in commercial herbal teas from Lamiaceae: peppermint, melissa, and age. J Agric Food Chem 55: 10908-10917.
15. Safra J, Pospísilová M, Honegr J, Spilková J. 2007. Determination of selected antioxidants in Melissae herba by isotachophoresis and capillary zone electrophoresis in the column-coupling configuration. J Chromatogr A 1171: 124-132.
16. Capecka E, Mareczek A, Leja M. 2005. Antioxidant activity of fresh and dry herbs of some Lamiaceae species. Food Chem 93:223-226.
17. Dastmalchi K, Dorman HJD, Oinonen PP, Darwis Y, Laakso I, Hiltunen R. 2008. Chemical composition and in vitro antioxidative activity of a lemon balm (Melissa officinalis L.) extract. Food Sci Techno 41: 391-400.
18. Kabala-Dzik A, Stojko R, Szaflarska-Stojko E, Wroblewska-Adamek I, Stojko A, Stojko J, Stawiarska-Pieta B. 2004. Influence of honeybalm on the rate of scare formation during experimental burn wound healing in PIGS. Bull Vet Inst Pulawy 48: 311-316.
19. Weiman Z, Alkrinawi S, Golfarb D, Bitran C. 1993. Efficacy of herbal tea preparation in infantile colic. The J Pediatr 122: 650-652.
20. Wake G, Court J, Pickering A, Lewis R, Wilkins R, Perry E. 1999. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol 69:105-114.
21. Friedewald WT, Ley RI, Fradrickson DS. 1972. Estimation of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. lin Chem 18: 499-502.
22. Wuttke W, Jarry H, Westphalen S, Christoffel V, Seidlova-Wuttke DJ. 2002. Phytoestrogens for hormone replacement therapy? Steroid Biochem Mol iol 83:133-147.
23. Gallo D, Zannoni GF, Apollonio P, Martinelli E, Ferlini C, Passetti G, Riva A, Morazzoni P, Bombardelli, E, Scambia G. 2005. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile. Menopause 12:589-00.
24. Junichi M, Kazuo E, Hiroshi O, Mikiharu D, Taro K, Kiyoshi E. 2007. Hypocholesterolemic effects of microbial protease-resistant fraction of katsuobushi in ovariectomized rats depend on the both oil and undigested protein. J Nutri Sci Vitaminol 53:508-514.
25. Bolkent S, Yanardag R, Karabulut-Bulan O, Yesilyaprak B. 2005. Protective role of Melissa officinalis L. extract on liver of hyperlipidaemic rats: A morphological and biochemical study. J Ethnopharmacol 99: 391-398.
26. Lee J, Chae K, Ha J, Park BY, Lee HS, Jeong S, Kim MY, Yoon M. 2008. Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice. J Ethnopharmacol 115:263-270.
27. Prasad K. 2005. Hypocholesterolemic and antiatherosclerotic effect of flax lignin complex isolated from flax seed. Atherosclerosis 179: 269-275.
28. Vijaimohan K, Jainu M, Sabitha KE, Subramaniyam S, Anandhan C, Shyamala Devi CS. 2006. Beneficial effects of alpha linolenic acid rich flax seed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rat. Life Sci 79:448-454.
29. Demacker PNM, Reijnen IGM, Katan MB, Stuyt PMJ, Stalenhoef AFH. 1991. Increased removal of remnants of triglyceride rich lipoproteins on a diet rich in polyunsaturated fatty acids. Eur J Clin Invest 21:197-203.
30. Goldstein JL, Kita T, Brown MS. 1983. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. N Engl J Med 309: 288-296.
31. Janus ED, Postiglione A, Singh RB, Lewis B. 1996. The modernization of Asia: implications for coronary heart disease. Circulation 94: 2671-2673.
32. Clegg RJ, Middleton B, Bell D, White DA. 1982. The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A eductase in vivo in the rat. J Biol Chem 257: 2294-2299.
33. Qureshi AA, Mangels WR, Din ZZ, Elson CE. 1988. Inhibition of hepatic mevalonate biosynthesis by the monoterpene, d-limonene. J Agric Food Chem 6: 1220-1224.
34. Polo MP, de Bravo MG. 2006. Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2. Biochem Cell Biol 4: 102-111.
35. Adinee J, Piri K, Karami O. 2008. Essential Oil Component in Flower of Lemon Balm (Melissa officinalis L.). Am J Biochem Biotech 4: 277-278.
36. Azarmi Y, Mohammdi A, Babaei H. 2009. Role of endothelium on relaxant effect of geraniol in isolated rat aorta. J Pharmaciut Sci 14:311-319.
37. Gazola R, Machado D, Ruggiero C, Singi G, Macedo Alexandre M. 2004. Lippia alba, Melissa officinalis and Cymbopogon citratus: effects of the aqueous extracts on the isolated hearts of rats. Pharmacol Res 50:477-80.
38. Holmes WL, DiTullio NW. 1962. Inhibitors of cholesterol biosynthesis which act at or beyond the mevalonic acid stage. Am J Clin Nutr 10: 310-322.
39. Lima CC, Criddle DN, Coelho-de-Souza AN, Monte FJ, Jaffar M, Leal-Cardoso JH. 2000. Relaxant and antispasmodic actions of methyl eugenol on uinea-pig isolated ileum. Planta Med 66:408-411.
40. Lahlou S, Figueiredo AF, Magalhãeh PJ, Leal-Cardoso JH, Gloria PD. 2004. Cardiovascular effects of methyleugenol, a natural constituent of many plant essential oils, in normotensive rats. Life Sci 74:2401-2412.
41. Germán C, Leticia G, Adrián S, Fermando L, Maria S, Elizdath M, Francisco D, Joaquin T. 1998. Hypolipidemic activity of dimethoxy unconjugated propenyl side-chain analogs of α-asarone in mice. Drug Dev Res 43:105-108.
42. Steinberg D. 1995. Role of oxidized LDL and antioxidants in atherosclerosis: Adv Exp Med Biol 369:39-48, 1995.
43. Niki E. 2004. Antioxidants and atherosclerosis. 2004. Biochem Soc Trans 32: 156-159.
44. Rajalakshmi K, Gurumurthi P, Devaraj SN. 2000. Effect of eugenol and tincture of crataegus (TCR) on in vivo oxidation of LDL+VLDL isolated from plasma of non-insulin dependent diabetic patients. Indian J Exp Biol 38:509-511.
45. Teissedre PL, Waterhouse AL. 2000. Inhibition of oxidation of human low density lipoproteins by phenolic substances in different essentials varieties. J gric Food Chem 48:3801-3805.
46. Mockute D, Bernotiene G, Judzentiene A. 2001. The essential oil of Origanum vulgare L. ssp. vulgare growing wild in vilnius district (Lithuania). hytochemistry 57:65-69.
47. Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. 2003. Volatile constituents from Cinnamomum zeylanicum fruit stalks and their antioxidant ctivities. J Agric Food Chem 51:4344-4348.
48. Patora J, Majda T, Góra J, Klimek B. 2003. Variability in the content and composition of essential oil from lemon balm (Melissa officinalis L.) cultivated n Poland. Acta Pol Pharm 60:395-400.
49. Orav A, Stulova I, Kailas T, Mϋϋrisepp M. 2004. Effect of storage on the essential oil composition of Piper nigrum L. fruits of different ripening states. J gric Food Chem 52:2582-2586.
50. Hendriks H, Malingre T, Battermann S, Boss R. 1975. Mono- and sesquiterpene hydrocarbons of the essential oil of Cannabis sativa. Phytochemistry 4:814-815.
51. Gertsch J, Leonti M, Raduner S, Racz I, Chen J-Z, Xie X-Q, Altmann K-H, Karsak M, Zimmer A. 2008. Beta-caryophyllene is a dietary cannabinoid. roc Natl Acad Sci USA 105:9099-104.
52. Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, Karsak M, Zimmer A, Frossard JL, Mach F. 2005. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434:782-786.